« Previous
Next »
American Heart Journal
Volume 146, Issue 5
, Pages 804-810
, November 2003
Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial
References
- Cardiogenic shock after acute myocardial infarction (incidence and mortality from a community wide perspective 1975–1988). N Engl J Med. 1991;325:1117–1122
- Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162–1168
- Current spectrum of cardiogenic shock and effect of early revascularization on mortality (results of an international registry). Circulation. 1995;91:873–881
- Cardiogenic shock complicating acute myocardial infarction (etiologies, management and outcome: a report from the SHOCK Trial Registry). J Am Coll Cardiol. 2000;36:1063–1070
- Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–634
- One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190–192
- Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) Trial (an observational study). Circulation. 1997;96:122–127
- Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction (results from the GUSTO Trial). Lancet. 1997;349:75–78
- The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction (data from the National Registry of Myocardial Infarction 2). Am Heart J. 2001;141:933–939
- Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction (a report from the SHOCK Trial Registry). J Am Coll Cardiol. 2000;36:1123–1129
- Should we emergently revascularize occluded coronaries for cardiogenic shock (an international randomized trial of emergency PTCA/CABG: trial design). Am Heart J. 1999;137:313–321
- . Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects (a prospective study). Circulation. 1986;74:469–476
-
Changing efficacy of coronary revascularization (implications for patient selection).
Circulation. 1988;78(Suppl I):I-185–191
-
Sanborn TA. Core laboratory angiographic findings, angioplasty results, and relation to treatment effect: results from the randomized SHOCK Trial. 48th Annual Scientific Sessions of the American College of Cardiology, 1999, New Orleans, La
-
Statistical Analysis System. (Version 8.2). Cary, NC: SAS Institute; 2002
- Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J. 2001;141:964–970
-
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.
Circulation. 2000;101:2239–2246
- . Thrombolytic therapy in the elderly. [commentary] Lancet. 2000;356:2028–2030
-
.
Thrombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) (results of a prospective randomized trial).
Circulation. 2000;102:600
-
Cardiogenic shock survival and use of intraaortic balloon counterpulsation (results from the GUSTO I and III Trials).
Circulation. 1999;100(Suppl I):I-370
☆ Supported by grants from the NHLBI (RO1-HL 50020 and HL-49970, 1994 to 1999, Bethesda, Md).
PII: S0002-8703(03)00392-2
doi: 10.1016/S0002-8703(03)00392-2
© 2003 Mosby, Inc. All rights reserved.
« Previous
Next »
American Heart Journal
Volume 146, Issue 5
, Pages 804-810
, November 2003
